Watchlist
Loading...
US Stock MarketDetailed Quotes

CFRX ContraFect

Watchlist
0.536 -0.029-5.19% Trading 09/21 11:34 ET
0.600High0.535Low22.57KVolume
Intraday
  • 5D
  • 1D
  • 1W
  • 1M
  • 1Q
  • 1Y

About ContraFect Company

ContraFect Corp. is a clinical stage biotechnology company, which engages in the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life-threatening, antibiotic-resistant infections. Its product pipeline consists of CF-301, Gram-Negative Lysins, and Amurin Peptides. The company was founded by Robert Nowinski on March 5, 2008 and is headquartered in Yonkers, NY.

Comments

Read more
Paper Trade Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Claim up to $1 million virtual fund, join moomoo paper trading today! Claim Now >